Atlas Trials

Clinical Study to Assess Safety, PK and PD Parameters of CDR132L

Clinical trial NCT04045405 · COMPLETED

Trial details

NCT number
NCT04045405
Sponsor
Cardior Pharmaceuticals GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure
Start date
2019-06-21
Primary completion
2020-01-31
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.